Trv Gp IV, LLC insider trades
Trv Gp IV, LLC has filed 8 Form 4s with the SEC that we hold, for Tango Therapeutics, Inc. (TNGX) (10% owner) and Dianthus Therapeutics, Inc. /DE/ (MGTA) (10% owner). Across all of them we count 0 purchases worth $0 and 10 sales worth $21.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($4.8M). The largest single trade was a sale of 477,401 shares of Tango Therapeutics, Inc. worth $4.8M, dated 2025-10-23. The first filing on our record is dated 2023-02-09 and the latest 2025-10-27.
Tango Therapeutics, Inc. (TNGX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-07-26 | S, sale reported on Form 4 | 50,000 | $492.0K | 2024-07-30 |
| 2024-09-05 | S, sale reported on Form 4 | 75,000 | $867.0K | 2024-09-09 |
| 2024-09-13 | S, sale reported on Form 4 | 67,400 | $709.7K | 2024-09-17 |
| 2025-09-05 | S, sale reported on Form 4 | 642,906 | $4.5M | 2025-09-09 |
| 2025-09-08 | S, sale reported on Form 4 | 86,459 | $608.7K | 2025-09-09 |
| 2025-09-16 | S, sale reported on Form 4 | 363,541 | $2.6M | 2025-09-17 |
| 2025-09-25 | S, sale reported on Form 4 | 500,000 | $4.0M | 2025-09-29 |
| 2025-10-23 | S, sale reported on Form 4 | 477,401 | $4.8M | 2025-10-27 |
Dianthus Therapeutics, Inc. /DE/ (MGTA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-02-07 | S, sale reported on Form 4 | 2,200,000 | $1.8M | 2023-02-09 |
| 2023-02-08 | S, sale reported on Form 4 | 1,500,000 | $1.2M | 2023-02-09 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1688325) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms